Immunic, Inc.
IMUX· Nasdaq
Filed Apr 10, 2019 · 10-Q · 10 days after period end · 0001280776-19-000032
| Metric | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|
| Net Income | -$4.31M | -$2.26M | -$12.60M | -$9.59M |
| EPS Diluted | -$5.09 | -$2.67 | -$0.39 | -$0.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR
ended Mar 31, 2019 · filed Apr 10, 2019 · 10 d after period end